Linh-Chi Ho

Ms. Linh-Chi Ho

University of Arkansas for Medical Sciences College of Medicine
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Sepideh MohammadhossinpourSepideh Mohammadhossinpour
Sepideh Mohammadhossinpour
LHLinh-Chi Ho
Linh-Chi Ho
LFLingling Fang
Lingling Fang
Jianfeng XuJianfeng Xu
Jianfeng Xu
FMFabricio Medina-Bolivar
Fabricio Medina-Bolivar
Triple-negative breast cancer (TNBC) is unresponsive to typical hormonal treatments, causing it to be one of the deadliest forms of breast cancer. Investigating alternative therapies to increase survival rates for this disease is essential. The goal of this study was to assess cytotoxicity and apoptosis mechanisms of prenylated stilbenoids in TNBC cells. The prenylated stilbenoids arachidin-1 (A-1) and arachidin-3 (A-3) are analogs of resveratrol (RES) produced in peanut upon biotic stress. The anticancer activity of A-1 and A-3 isolated from peanut hairy root cultures was determined in TNBC cell lines MDA-MB-231 and MDA-MB-436. After 24 h of treatment, A-1 exhibited higher cytotoxicity than A-3 and RES with approximately 11-fold and six-fold lower IC50, respectively, in MDA-MB-231 cells, and nine-fold and eight-fold lower IC50, respectively, in MDA-MB-436 cells. A-1 did not show significant cytotoxicity in the non-cancerous cell line MCF-10A. While A-1 blocked cell division in G2-M phases in the TNBC cells, it did not affect cell division in MCF-10A cells. Furthermore, A-1 induced caspase-dependent apoptosis through the intrinsic pathway by activating caspase-9 and PARP cleavage, and inhibiting survivin. In conclusion, A-1 merits further research as a potential lead molecule for the treatment of TNBC.

7 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
Sepideh MohammadhossinpourSepideh Mohammadhossinpour
Sepideh Mohammadhossinpour
AWAlexx Weaver
Alexx Weaver
MSmeenakshi sudhakaran
meenakshi sudhakaran
LHLinh-Chi Ho
Linh-Chi Ho
TLTra Le
Tra Le
FMFabricio Medina-Bolivar
Fabricio Medina-Bolivar
Triple-negative breast cancer (TNBC) is one of the deadliest forms of breast cancer. Investigating alternative therapies to increase survival rates for this disease is essential. To this end, the cytotoxic effects of the prenylated stilbenoids arachidin-1 (A-1) and arachidin-3 (A-3), and non-prenylated resveratrol (RES) were evaluated in human TNBC cell lines as potential adjuvants for paclitaxel (Pac). A-1, alone or in combination with Pac, showed the highest cytotoxicity in TNBC cells. Apoptosis was further evaluated by measuring key apoptosis marker proteins, cell cycle arrest, and intracellular reactive oxygen species (ROS) generation. Furthermore, the cytotoxic effect of A-1 combined with Pac was also evaluated in a 3D spheroid TNBC model. The results showed that A-1 decreased the Pac IC50 approximately 2-fold in TNBC cells. The synergistic combination of A-1 and Pac arrested cells in G2/M phase and activated p53 expression. In addition, the combined treatment increased intracellular ROS generation and induced apoptosis. Importantly, the combination of A-1 with Pac inhibited TNBC spheroid growth. Our results demonstrated that A-1 in combination with Pac inhibited cell proliferation, induced apoptosis through mitochondrial oxidative stress, and reduced TNBC spheroid growth. These findings underscore the impactful effects of the prenylated stilbenoid A-1 as a novel adjuvant for Pac chemotherapy in TNBC treatment.

13 April 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Sepideh MohammadhossinpourSepideh Mohammadhossinpour
Sepideh Mohammadhossinpour
AWAlexx Weaver
Alexx Weaver
LHLinh-Chi Ho
Linh-Chi Ho
FMFabricio Medina-Bolivar
Fabricio Medina-Bolivar